Halozyme Therapeutics (HALO) 14.73 $HALO
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
39.1% Return Seen to Date on SmarTrend Halozyme Therapeutics Call (HALO)
Comtex SmarTrend(R) - Tue Feb 10, 5:03PM CST
SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on January 5th, 2015 at $9.95. In approximately 1 month, Halozyme Therapeutics has returned 39.10% as of today's recent price of $13.84.
HALO: 14.73 (+0.23)
Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma
PR Newswire - Wed Jan 28, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: Halozyme Therapeutics Inc. (NASDAQ: HALO), Agenus Inc. (NASDAQ: AGEN), Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research report on Halozyme Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Halozyme%...amp;s=HALO. On Tuesday, January 27, 2015, the NASDAQ Composite ended at 4,681.50, down 1.89%, the Dow Jones Industrial Average declined 1.65%, to finish the day at 17,387.21, and the S&P 500 closed at 2,029.55, down 1.34%. The losses were broad based as nine out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 818.80, down 0.75%, while the index has advanced 8.40% in the previous three months. Register for your complimentary reports at the links given below.
AGEN: 5.03 (-0.01), BIIB: 391.66 (-0.45), ACAD: 34.21 (+0.37), HALO: 14.73 (+0.23), PPHM: 1.28 (+0.03)
Halozyme Therapeutics Up 46.1% Since SmarTrend Uptrend Call (HALO)
Comtex SmarTrend(R) - Tue Jan 27, 9:36AM CST
SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on January 5th, 2015 at $9.95. In approximately 3 weeks, Halozyme Therapeutics has returned 46.13% as of today's recent price of $14.54.
HALO: 14.73 (+0.23)
Halozyme Appoints Jean-Pierre Bizzari, M.D. To Board Of Directors
PR Newswire - Wed Jan 21, 7:30AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr. Bizzari brings extensive experience in oncology drug development.
HALO: 14.73 (+0.23)
Halozyme Therapeutics Has Returned 46.1% Since SmarTrend Recommendation (HALO)
Comtex SmarTrend(R) - Tue Jan 20, 9:06AM CST
SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on January 5th, 2015 at $9.95. In approximately 2 weeks, Halozyme Therapeutics has returned 46.07% as of today's recent price of $14.53.
HALO: 14.73 (+0.23)
Jim Cramer's Top Stock Picks: AAPL FLEX DIS CELG HALO
at The Street - Wed Jan 14, 5:00AM CST
Disney and Celgene have bankable CEOs while Halogen Therapeutics is involved in some promising treatments.
FLEX: 12.05 (-0.09), HALO: 14.73 (+0.23), DIS: 104.17 (+0.59), AAPL: 127.08 (+0.62), CELG: 115.88 (+0.16)
Cramer's Mad Money: A Different Kind Of Market (1/13/15)
SA Editor Michael Hopkins - at Seeking Alpha - Tue Jan 13, 11:37PM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, January 13. What appeared to be a promising start for the market Tuesday quickly eroded into losses. Usually there is a big reason for this type of roller...
FLEX: 12.05 (-0.09), TSLA: 203.77 (+0.89), AMZN: 381.83 (+4.66), HALO: 14.73 (+0.23), DIS: 104.17 (+0.59), KBH: 14.39 (+0.26), TLT: 128.19 (-1.33), AAPL: 127.08 (+0.62), CELG: 115.88 (+0.16)
Jim Cramer's 'Mad Money' Recap: How to Maneuver in a Trader's Market
at The Street - Tue Jan 13, 7:20PM CST
Investors can either find stocks they like and watch them like a hawk or sell into strength and buy into weakness, Cramer says.
FLEX: 12.05 (-0.09), KMI: 41.97 (+0.21), TSLA: 203.77 (+0.89), AMZN: 381.83 (+4.66), MDLZ: 36.78 (-0.20), DIS: 104.17 (+0.59), KRFT: 64.42 (-1.75), TLT: 128.19 (-1.33), LUV: 43.30 (-0.20), CELG: 115.88 (+0.16), VLO: 58.60 (+2.05), AA: 15.81 (+0.16), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), AAL: 48.39 (+0.51), KBH: 14.39 (+0.26), AAPL: 127.08 (+0.62), MA: 87.14 (-0.38), URI: 92.98 (+1.41)
Halozyme Therapeutics Provides An Update On Anticipated Milestones For 2015 At The 33rd Annual J. P. Morgan Healthcare Conference
PR Newswire - Mon Jan 12, 8:00AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today provided an update on anticipated 2015 corporate milestones.
HALO: 14.73 (+0.23)
'Mad Money' Lightning Round: Be Careful Investing in Google
at The Street - Sat Jan 10, 5:00AM CST
Cramer was bearish on Cliffs Natural Resources, Royal Dutch Shell and Halozyme Therapeutics.
AUO: 5.45 (-0.14), RDS.A: 66.32 (+0.97), HALO: 14.73 (+0.23), EVEP: 16.83 (+0.26), GOOGL: 551.16 (+5.15), CLF: 7.00 (+0.35)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jan 09, 7:19PM CST
Earnings season is back and Cramer will be watching Alcoa and CSX, among others.
AUO: 5.45 (-0.14), MNST: 117.74 (-1.77), LM: 57.84 (-0.25), INTC: 34.36 (+0.23), SLB: 88.38 (+2.42), JPM: 59.67 (+0.10), TGT: 76.12 (-0.75), DD: 76.18 (-0.11), GOOGL: 551.16 (+5.15), PPG: 236.77 (+3.74), HD: 111.89 (-0.27), INCY: 75.94 (+0.28), IR: 67.69 (+0.06), WFC: 55.33 (+0.47), CLF: 7.00 (+0.35), GSK: 47.94 (+1.99), CSX: 36.08 (-0.49), MS: 36.78 (-0.12), AGEN: 5.03 (-0.01), AA: 15.81 (+0.16), LEN: 49.98 (-0.28), HALO: 14.73 (+0.23), GS: 189.00 (-0.78), EVEP: 16.83 (+0.26), RDS.A: 66.32 (+0.97), WEN: 10.95 (-0.15)
Nasdaq stocks posting largest percentage increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
LOXO: 11.91 (-0.24), ELOS: 10.16 (+0.07), AMBA: 50.71 (-4.46), RGEN: 24.77 (-0.73), ADXS: 7.18 (+0.06), NBIX: 37.22 (+0.27), PDFS: 18.31 (+0.04), HALO: 14.73 (+0.23), VLCCF: 4.15 (-0.06), PKT: 8.99 (+0.11), ARNA: 4.55 (+0.02)
Halozyme up on upgrade
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:14AM CST
HALO: 14.73 (+0.23)
Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver
PR Newswire - Thu Jan 08, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for KMI, HALO, MNKD, BP and UNP.
KMI: 41.97 (+0.21), HALO: 14.73 (+0.23), BP: 41.93 (+0.59), MNKD: 7.00 (+0.02), UNP: 122.60 (-1.23)
Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony
PR Newswire - Thu Jan 08, 6:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Dick's Sporting (NYSE: DKS), Monsanto (NYSE: MON), Halozyme (NASDAQ: HALO), Janus Capital (NYSE: JNS), and Sony (NYSE: SNE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
HALO: 14.73 (+0.23), MON: 124.77 (+2.00), DKS: 53.95 (+0.47), JNS: 17.38 (+0.24), SNE: 27.30 (+0.19)
Halozyme Provides Agenda Highlights For Analyst And Investor Meeting
PR Newswire - Wed Jan 07, 7:00AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today will review the PEGPH20 development program and provide 2015 financial guidance during a meeting for analysts and investors in New York at 10:00 a.m. ET/ 7:00 a.m. PT.
HALO: 14.73 (+0.23)
Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Jan 06, 3:30PM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2015 at 4:00 p.m. PT / 7:00 p.m. ET. Dr. Helen Torley, President and Chief Executive Officer, will provide a corporate overview.
HALO: 14.73 (+0.23), JPM: 59.67 (+0.10)
Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer
PR Newswire - Mon Jan 05, 7:30AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Athena Countouriotis, M.D., as Chief Medical Officer where she will be responsible for directing Halozyme's research, clinical development and regulatory activities.
HALO: 14.73 (+0.23)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
39.1% Return Seen to Date on SmarTrend Halozyme Therapeutics Call (HALO)
Comtex SmarTrend(R) - Tue Feb 10, 5:03PM CST
SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on January 5th, 2015 at $9.95. In approximately 1 month, Halozyme Therapeutics has returned 39.10% as of today's recent price of $13.84.
HALO: 14.73 (+0.23)
Biotech Stocks Technical Report - Halozyme Therapeutics, Agenus, Biogen Idec, ACADIA Pharma, and Peregrine Pharma
PR Newswire - Wed Jan 28, 7:40AM CST
Investor-Edge has initiated coverage on the following equities: Halozyme Therapeutics Inc. (NASDAQ: HALO), Agenus Inc. (NASDAQ: AGEN), Biogen Idec Inc. (NASDAQ: BIIB), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), and Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM). Free research report on Halozyme Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Halozyme%...amp;s=HALO. On Tuesday, January 27, 2015, the NASDAQ Composite ended at 4,681.50, down 1.89%, the Dow Jones Industrial Average declined 1.65%, to finish the day at 17,387.21, and the S&P 500 closed at 2,029.55, down 1.34%. The losses were broad based as nine out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 818.80, down 0.75%, while the index has advanced 8.40% in the previous three months. Register for your complimentary reports at the links given below.
AGEN: 5.03 (-0.01), BIIB: 391.66 (-0.45), ACAD: 34.21 (+0.37), HALO: 14.73 (+0.23), PPHM: 1.28 (+0.03)
Halozyme Therapeutics Up 46.1% Since SmarTrend Uptrend Call (HALO)
Comtex SmarTrend(R) - Tue Jan 27, 9:36AM CST
SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on January 5th, 2015 at $9.95. In approximately 3 weeks, Halozyme Therapeutics has returned 46.13% as of today's recent price of $14.54.
HALO: 14.73 (+0.23)
Halozyme Appoints Jean-Pierre Bizzari, M.D. To Board Of Directors
PR Newswire - Wed Jan 21, 7:30AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr. Bizzari brings extensive experience in oncology drug development.
HALO: 14.73 (+0.23)
Halozyme Therapeutics Has Returned 46.1% Since SmarTrend Recommendation (HALO)
Comtex SmarTrend(R) - Tue Jan 20, 9:06AM CST
SmarTrend identified an Uptrend for Halozyme Therapeutics (NASDAQ:HALO) on January 5th, 2015 at $9.95. In approximately 2 weeks, Halozyme Therapeutics has returned 46.07% as of today's recent price of $14.53.
HALO: 14.73 (+0.23)
Jim Cramer's Top Stock Picks: AAPL FLEX DIS CELG HALO
at The Street - Wed Jan 14, 5:00AM CST
Disney and Celgene have bankable CEOs while Halogen Therapeutics is involved in some promising treatments.
FLEX: 12.05 (-0.09), HALO: 14.73 (+0.23), DIS: 104.17 (+0.59), AAPL: 127.08 (+0.62), CELG: 115.88 (+0.16)
Cramer's Mad Money: A Different Kind Of Market (1/13/15)
SA Editor Michael Hopkins - at Seeking Alpha - Tue Jan 13, 11:37PM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, January 13. What appeared to be a promising start for the market Tuesday quickly eroded into losses. Usually there is a big reason for this type of roller...
FLEX: 12.05 (-0.09), TSLA: 203.77 (+0.89), AMZN: 381.83 (+4.66), HALO: 14.73 (+0.23), DIS: 104.17 (+0.59), KBH: 14.39 (+0.26), TLT: 128.19 (-1.33), AAPL: 127.08 (+0.62), CELG: 115.88 (+0.16)
Jim Cramer's 'Mad Money' Recap: How to Maneuver in a Trader's Market
at The Street - Tue Jan 13, 7:20PM CST
Investors can either find stocks they like and watch them like a hawk or sell into strength and buy into weakness, Cramer says.
FLEX: 12.05 (-0.09), KMI: 41.97 (+0.21), TSLA: 203.77 (+0.89), AMZN: 381.83 (+4.66), MDLZ: 36.78 (-0.20), DIS: 104.17 (+0.59), KRFT: 64.42 (-1.75), TLT: 128.19 (-1.33), LUV: 43.30 (-0.20), CELG: 115.88 (+0.16), VLO: 58.60 (+2.05), AA: 15.81 (+0.16), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), AAL: 48.39 (+0.51), KBH: 14.39 (+0.26), AAPL: 127.08 (+0.62), MA: 87.14 (-0.38), URI: 92.98 (+1.41)
Halozyme Therapeutics Provides An Update On Anticipated Milestones For 2015 At The 33rd Annual J. P. Morgan Healthcare Conference
PR Newswire - Mon Jan 12, 8:00AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today provided an update on anticipated 2015 corporate milestones.
HALO: 14.73 (+0.23)
'Mad Money' Lightning Round: Be Careful Investing in Google
at The Street - Sat Jan 10, 5:00AM CST
Cramer was bearish on Cliffs Natural Resources, Royal Dutch Shell and Halozyme Therapeutics.
AUO: 5.45 (-0.14), RDS.A: 66.32 (+0.97), HALO: 14.73 (+0.23), EVEP: 16.83 (+0.26), GOOGL: 551.16 (+5.15), CLF: 7.00 (+0.35)
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Jan 09, 7:19PM CST
Earnings season is back and Cramer will be watching Alcoa and CSX, among others.
AUO: 5.45 (-0.14), MNST: 117.74 (-1.77), LM: 57.84 (-0.25), INTC: 34.36 (+0.23), SLB: 88.38 (+2.42), JPM: 59.67 (+0.10), TGT: 76.12 (-0.75), DD: 76.18 (-0.11), GOOGL: 551.16 (+5.15), PPG: 236.77 (+3.74), HD: 111.89 (-0.27), INCY: 75.94 (+0.28), IR: 67.69 (+0.06), WFC: 55.33 (+0.47), CLF: 7.00 (+0.35), GSK: 47.94 (+1.99), CSX: 36.08 (-0.49), MS: 36.78 (-0.12), AGEN: 5.03 (-0.01), AA: 15.81 (+0.16), LEN: 49.98 (-0.28), HALO: 14.73 (+0.23), GS: 189.00 (-0.78), EVEP: 16.83 (+0.26), RDS.A: 66.32 (+0.97), WEN: 10.95 (-0.15)
Nasdaq stocks posting largest percentage increases
AP - Thu Jan 08, 5:10PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
LOXO: 11.91 (-0.24), ELOS: 10.16 (+0.07), AMBA: 50.71 (-4.46), RGEN: 24.77 (-0.73), ADXS: 7.18 (+0.06), NBIX: 37.22 (+0.27), PDFS: 18.31 (+0.04), HALO: 14.73 (+0.23), VLCCF: 4.15 (-0.06), PKT: 8.99 (+0.11), ARNA: 4.55 (+0.02)
Halozyme up on upgrade
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 11:14AM CST
HALO: 14.73 (+0.23)
Critical Alerts For Kinder Morgan, Halozyme Therapeutics, MannKind, BP and Union Pacific Released By InvestorsObserver
PR Newswire - Thu Jan 08, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for KMI, HALO, MNKD, BP and UNP.
KMI: 41.97 (+0.21), HALO: 14.73 (+0.23), BP: 41.93 (+0.59), MNKD: 7.00 (+0.02), UNP: 122.60 (-1.23)
Rallying on Street: Special Research on Dick's Sporting, Monsanto, Halozyme, Janus Capital and Sony
PR Newswire - Thu Jan 08, 6:30AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Dick's Sporting (NYSE: DKS), Monsanto (NYSE: MON), Halozyme (NASDAQ: HALO), Janus Capital (NYSE: JNS), and Sony (NYSE: SNE). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
HALO: 14.73 (+0.23), MON: 124.77 (+2.00), DKS: 53.95 (+0.47), JNS: 17.38 (+0.24), SNE: 27.30 (+0.19)
Halozyme Provides Agenda Highlights For Analyst And Investor Meeting
PR Newswire - Wed Jan 07, 7:00AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today will review the PEGPH20 development program and provide 2015 financial guidance during a meeting for analysts and investors in New York at 10:00 a.m. ET/ 7:00 a.m. PT.
HALO: 14.73 (+0.23)
Halozyme Therapeutics To Present At The 33rd Annual J.P. Morgan Healthcare Conference
PR Newswire - Tue Jan 06, 3:30PM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 13, 2015 at 4:00 p.m. PT / 7:00 p.m. ET. Dr. Helen Torley, President and Chief Executive Officer, will provide a corporate overview.
HALO: 14.73 (+0.23), JPM: 59.67 (+0.10)
Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer
PR Newswire - Mon Jan 05, 7:30AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Athena Countouriotis, M.D., as Chief Medical Officer where she will be responsible for directing Halozyme's research, clinical development and regulatory activities.
HALO: 14.73 (+0.23)
